HEADER SIGNALING PROTEIN 01-JUL-21 7F83 TITLE CRYSTAL STRUCTURE OF A RECEPTOR IN COMPLEX WITH INVERSE AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: GROWTH HORMONE SECRETAGOGUE RECEPTOR TYPE 1,SOLUBLE COMPND 3 CYTOCHROME B562; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: GHS-R,GH-RELEASING PEPTIDE RECEPTOR,GHRP,GHRELIN RECEPTOR, COMPND 6 CYTOCHROME B-562; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: GHSR, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, GHRELIN, INVERSE AGONIST, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.XU,Z.SHAO REVDAT 3 29-NOV-23 7F83 1 REMARK REVDAT 2 26-JAN-22 7F83 1 JRNL REVDAT 1 19-JAN-22 7F83 0 JRNL AUTH J.QIN,Y.CAI,Z.XU,Q.MING,S.Y.JI,C.WU,H.ZHANG,C.MAO,D.D.SHEN, JRNL AUTH 2 K.HIRATA,Y.MA,W.YAN,Y.ZHANG,Z.SHAO JRNL TITL MOLECULAR MECHANISM OF AGONISM AND INVERSE AGONISM IN JRNL TITL 2 GHRELIN RECEPTOR. JRNL REF NAT COMMUN V. 13 300 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 35027551 JRNL DOI 10.1038/S41467-022-27975-9 REMARK 2 REMARK 2 RESOLUTION. 2.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2-4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 25289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1239 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.7800 - 6.1100 1.00 2803 111 0.2148 0.2224 REMARK 3 2 6.1100 - 4.8500 1.00 2690 146 0.2465 0.3043 REMARK 3 3 4.8500 - 4.2400 1.00 2649 147 0.2118 0.2389 REMARK 3 4 4.2400 - 3.8500 1.00 2664 158 0.2084 0.2541 REMARK 3 5 3.8500 - 3.5800 1.00 2691 128 0.2140 0.2503 REMARK 3 6 3.5800 - 3.3700 1.00 2634 149 0.2388 0.2707 REMARK 3 7 3.3700 - 3.2000 1.00 2672 123 0.2429 0.3060 REMARK 3 8 3.2000 - 3.0600 1.00 2619 159 0.2600 0.3318 REMARK 3 9 3.0600 - 2.9400 1.00 2628 118 0.2729 0.3308 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.415 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.565 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6367 REMARK 3 ANGLE : 1.031 8633 REMARK 3 CHIRALITY : 0.052 1004 REMARK 3 PLANARITY : 0.009 1053 REMARK 3 DIHEDRAL : 26.395 942 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7F83 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300022857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25315 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.940 REMARK 200 RESOLUTION RANGE LOW (A) : 39.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 24.53 REMARK 200 R MERGE (I) : 0.66400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 23.68 REMARK 200 R MERGE FOR SHELL (I) : 5.08300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.310 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 6KO5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES, PH 7.0, 25%-36% PEG300, REMARK 280 80MM - 150MM NH4F, LIPIDIC CUBIC PHASE, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.34000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 152 REMARK 465 VAL A 153 REMARK 465 VAL A 154 REMARK 465 VAL A 155 REMARK 465 GLU A 187 REMARK 465 GLN A 188 REMARK 465 GLY A 189 REMARK 465 THR A 190 REMARK 465 ASP A 191 REMARK 465 PRO A 192 REMARK 465 GLY A 1001 REMARK 465 LEU A 253 REMARK 465 GLU A 341 REMARK 465 PRO A 342 REMARK 465 GLU A 343 REMARK 465 ASN A 344 REMARK 465 LEU A 345 REMARK 465 TYR A 346 REMARK 465 PHE A 347 REMARK 465 GLN A 348 REMARK 465 LYS B 152 REMARK 465 VAL B 153 REMARK 465 VAL B 154 REMARK 465 VAL B 155 REMARK 465 GLU B 187 REMARK 465 GLN B 188 REMARK 465 GLY B 189 REMARK 465 THR B 190 REMARK 465 ASP B 191 REMARK 465 PRO B 192 REMARK 465 TRP B 193 REMARK 465 ASP B 194 REMARK 465 ARG B 243 REMARK 465 GLY B 1087 REMARK 465 LYS B 1088 REMARK 465 VAL B 1089 REMARK 465 LYS B 1090 REMARK 465 LEU B 253 REMARK 465 ARG B 254 REMARK 465 GLU B 341 REMARK 465 PRO B 342 REMARK 465 GLU B 343 REMARK 465 ASN B 344 REMARK 465 LEU B 345 REMARK 465 TYR B 346 REMARK 465 PHE B 347 REMARK 465 GLN B 348 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A1033 CG OD1 OD2 REMARK 470 ASP A1055 CG OD1 OD2 REMARK 470 GLU B1009 CD OE1 OE2 REMARK 470 THR B1014 OG1 CG2 REMARK 470 LEU B1015 CG CD1 CD2 REMARK 470 ASP B1017 CG OD1 OD2 REMARK 470 ASN B1018 CG OD1 ND2 REMARK 470 LEU B1019 CG CD1 CD2 REMARK 470 LYS B1020 CG CD CE NZ REMARK 470 VAL B1021 CG1 CG2 REMARK 470 ILE B1022 CG1 CG2 CD1 REMARK 470 GLU B1023 CG CD OE1 OE2 REMARK 470 LYS B1024 CG CD CE NZ REMARK 470 ASP B1026 CG OD1 OD2 REMARK 470 ASN B1027 CG OD1 ND2 REMARK 470 GLN B1030 CG CD OE1 NE2 REMARK 470 VAL B1031 CG1 CG2 REMARK 470 LYS B1032 CG CD CE NZ REMARK 470 ASP B1033 CG OD1 OD2 REMARK 470 LYS B1037 CG CD CE NZ REMARK 470 MET B1038 CG SD CE REMARK 470 ARG B1039 CG CD NE CZ NH1 NH2 REMARK 470 LEU B1043 CG CD1 CD2 REMARK 470 ASP B1044 CG OD1 OD2 REMARK 470 GLN B1046 CG CD OE1 NE2 REMARK 470 LYS B1047 CG CD CE NZ REMARK 470 LEU B1053 CG CD1 CD2 REMARK 470 GLU B1054 CG CD OE1 OE2 REMARK 470 LYS B1056 CG CD CE NZ REMARK 470 GLU B1062 CG CD OE1 OE2 REMARK 470 MET B1063 CG SD CE REMARK 470 LYS B1064 CG CD CE NZ REMARK 470 ASP B1065 CG OD1 OD2 REMARK 470 PHE B1066 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B1067 CG CD NE CZ NH1 NH2 REMARK 470 HIS B1068 CG ND1 CD2 CE1 NE2 REMARK 470 PHE B1070 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B1071 CG OD1 OD2 REMARK 470 ILE B1072 CG1 CG2 CD1 REMARK 470 LEU B1073 CG CD1 CD2 REMARK 470 VAL B1074 CG1 CG2 REMARK 470 GLN B1076 CG CD OE1 NE2 REMARK 470 ILE B1077 CG1 CG2 CD1 REMARK 470 ASP B1078 CG OD1 OD2 REMARK 470 ASP B1079 CG OD1 OD2 REMARK 470 LEU B1081 CG CD1 CD2 REMARK 470 LYS B1082 CG CD CE NZ REMARK 470 LEU B1083 CG CD1 CD2 REMARK 470 GLU B1086 CG CD OE1 OE2 REMARK 470 GLU B1091 CG CD OE1 OE2 REMARK 470 GLN B1093 CG CD OE1 NE2 REMARK 470 GLU B1097 CG CD OE1 OE2 REMARK 470 GLN B1098 CG CD OE1 NE2 REMARK 470 LEU B1099 CG CD1 CD2 REMARK 470 LYS B1100 CG CD CE NZ REMARK 470 THR B1101 OG1 CG2 REMARK 470 ARG B1103 CG CD NE CZ NH1 NH2 REMARK 470 ASN B1104 CG OD1 ND2 REMARK 470 TYR B1106 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE B1107 CG1 CG2 CD1 REMARK 470 GLN B1108 CG CD OE1 NE2 REMARK 470 LYS B1109 CG CD CE NZ REMARK 470 TYR B1110 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LEU B1111 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG A 243 N GLY A 1002 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A1026 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG B 150 NE - CZ - NH1 ANGL. DEV. = -4.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 75 58.41 -90.21 REMARK 500 ARG A 107 77.48 -103.83 REMARK 500 ASN A 196 61.96 -167.21 REMARK 500 VAL A 230 -63.50 -91.00 REMARK 500 THR A1003 -159.93 -128.06 REMARK 500 LYS A1088 75.32 -117.76 REMARK 500 TRP B 240 54.75 -114.00 REMARK 500 ASP B1059 -5.32 -151.64 REMARK 500 PHE B 290 -67.63 -91.38 REMARK 500 SER B 294 10.96 -67.99 REMARK 500 LEU B 295 -66.70 -96.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 197 CYS A 198 147.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 1201 REMARK 610 OLC B 1201 REMARK 610 OLC B 1202 DBREF 7F83 A 35 243 UNP Q92847 GHSR_HUMAN 35 243 DBREF 7F83 A 1006 1111 UNP P0ABE7 C562_ECOLX 23 128 DBREF 7F83 A 253 342 UNP Q92847 GHSR_HUMAN 253 342 DBREF 7F83 B 35 243 UNP Q92847 GHSR_HUMAN 35 243 DBREF 7F83 B 1006 1111 UNP P0ABE7 C562_ECOLX 23 128 DBREF 7F83 B 253 342 UNP Q92847 GHSR_HUMAN 253 342 SEQADV 7F83 LYS A 130 UNP Q92847 THR 130 ENGINEERED MUTATION SEQADV 7F83 GLN A 188 UNP Q92847 ASN 188 ENGINEERED MUTATION SEQADV 7F83 GLY A 1001 UNP Q92847 LINKER SEQADV 7F83 GLY A 1002 UNP Q92847 LINKER SEQADV 7F83 THR A 1003 UNP Q92847 LINKER SEQADV 7F83 THR A 1004 UNP Q92847 LINKER SEQADV 7F83 MET A 1005 UNP Q92847 LINKER SEQADV 7F83 TRP A 1012 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 7F83 ILE A 1107 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 7F83 LEU A 1111 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 7F83 GLU A 343 UNP Q92847 EXPRESSION TAG SEQADV 7F83 ASN A 344 UNP Q92847 EXPRESSION TAG SEQADV 7F83 LEU A 345 UNP Q92847 EXPRESSION TAG SEQADV 7F83 TYR A 346 UNP Q92847 EXPRESSION TAG SEQADV 7F83 PHE A 347 UNP Q92847 EXPRESSION TAG SEQADV 7F83 GLN A 348 UNP Q92847 EXPRESSION TAG SEQADV 7F83 LYS B 130 UNP Q92847 THR 130 ENGINEERED MUTATION SEQADV 7F83 GLN B 188 UNP Q92847 ASN 188 ENGINEERED MUTATION SEQADV 7F83 GLY B 1001 UNP Q92847 LINKER SEQADV 7F83 GLY B 1002 UNP Q92847 LINKER SEQADV 7F83 THR B 1003 UNP Q92847 LINKER SEQADV 7F83 THR B 1004 UNP Q92847 LINKER SEQADV 7F83 MET B 1005 UNP Q92847 LINKER SEQADV 7F83 TRP B 1012 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 7F83 ILE B 1107 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 7F83 LEU B 1111 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 7F83 GLU B 343 UNP Q92847 EXPRESSION TAG SEQADV 7F83 ASN B 344 UNP Q92847 EXPRESSION TAG SEQADV 7F83 LEU B 345 UNP Q92847 EXPRESSION TAG SEQADV 7F83 TYR B 346 UNP Q92847 EXPRESSION TAG SEQADV 7F83 PHE B 347 UNP Q92847 EXPRESSION TAG SEQADV 7F83 GLN B 348 UNP Q92847 EXPRESSION TAG SEQRES 1 A 416 LEU GLN LEU PHE PRO ALA PRO LEU LEU ALA GLY VAL THR SEQRES 2 A 416 ALA THR CYS VAL ALA LEU PHE VAL VAL GLY ILE ALA GLY SEQRES 3 A 416 ASN LEU LEU THR MET LEU VAL VAL SER ARG PHE ARG GLU SEQRES 4 A 416 LEU ARG THR THR THR ASN LEU TYR LEU SER SER MET ALA SEQRES 5 A 416 PHE SER ASP LEU LEU ILE PHE LEU CYS MET PRO LEU ASP SEQRES 6 A 416 LEU VAL ARG LEU TRP GLN TYR ARG PRO TRP ASN PHE GLY SEQRES 7 A 416 ASP LEU LEU CYS LYS LEU PHE GLN PHE VAL SER GLU SER SEQRES 8 A 416 CYS THR TYR ALA LYS VAL LEU THR ILE THR ALA LEU SER SEQRES 9 A 416 VAL GLU ARG TYR PHE ALA ILE CYS PHE PRO LEU ARG ALA SEQRES 10 A 416 LYS VAL VAL VAL THR LYS GLY ARG VAL LYS LEU VAL ILE SEQRES 11 A 416 PHE VAL ILE TRP ALA VAL ALA PHE CYS SER ALA GLY PRO SEQRES 12 A 416 ILE PHE VAL LEU VAL GLY VAL GLU HIS GLU GLN GLY THR SEQRES 13 A 416 ASP PRO TRP ASP THR ASN GLU CYS ARG PRO THR GLU PHE SEQRES 14 A 416 ALA VAL ARG SER GLY LEU LEU THR VAL MET VAL TRP VAL SEQRES 15 A 416 SER SER ILE PHE PHE PHE LEU PRO VAL PHE CYS LEU THR SEQRES 16 A 416 VAL LEU TYR SER LEU ILE GLY ARG LYS LEU TRP ARG ARG SEQRES 17 A 416 ARG GLY GLY THR THR MET ALA ASP LEU GLU ASP ASN TRP SEQRES 18 A 416 GLU THR LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA SEQRES 19 A 416 ASP ASN ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET SEQRES 20 A 416 ARG ALA ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO SEQRES 21 A 416 LYS LEU GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS SEQRES 22 A 416 ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE SEQRES 23 A 416 ASP ASP ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS SEQRES 24 A 416 GLU ALA GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG SEQRES 25 A 416 ASN ALA TYR ILE GLN LYS TYR LEU LEU ARG ASP GLN ASN SEQRES 26 A 416 HIS LYS GLN THR VAL LYS MET LEU ALA VAL VAL VAL PHE SEQRES 27 A 416 ALA PHE ILE LEU CYS TRP LEU PRO PHE HIS VAL GLY ARG SEQRES 28 A 416 TYR LEU PHE SER LYS SER PHE GLU PRO GLY SER LEU GLU SEQRES 29 A 416 ILE ALA GLN ILE SER GLN TYR CYS ASN LEU VAL SER PHE SEQRES 30 A 416 VAL LEU PHE TYR LEU SER ALA ALA ILE ASN PRO ILE LEU SEQRES 31 A 416 TYR ASN ILE MET SER LYS LYS TYR ARG VAL ALA VAL PHE SEQRES 32 A 416 ARG LEU LEU GLY PHE GLU PRO GLU ASN LEU TYR PHE GLN SEQRES 1 B 416 LEU GLN LEU PHE PRO ALA PRO LEU LEU ALA GLY VAL THR SEQRES 2 B 416 ALA THR CYS VAL ALA LEU PHE VAL VAL GLY ILE ALA GLY SEQRES 3 B 416 ASN LEU LEU THR MET LEU VAL VAL SER ARG PHE ARG GLU SEQRES 4 B 416 LEU ARG THR THR THR ASN LEU TYR LEU SER SER MET ALA SEQRES 5 B 416 PHE SER ASP LEU LEU ILE PHE LEU CYS MET PRO LEU ASP SEQRES 6 B 416 LEU VAL ARG LEU TRP GLN TYR ARG PRO TRP ASN PHE GLY SEQRES 7 B 416 ASP LEU LEU CYS LYS LEU PHE GLN PHE VAL SER GLU SER SEQRES 8 B 416 CYS THR TYR ALA LYS VAL LEU THR ILE THR ALA LEU SER SEQRES 9 B 416 VAL GLU ARG TYR PHE ALA ILE CYS PHE PRO LEU ARG ALA SEQRES 10 B 416 LYS VAL VAL VAL THR LYS GLY ARG VAL LYS LEU VAL ILE SEQRES 11 B 416 PHE VAL ILE TRP ALA VAL ALA PHE CYS SER ALA GLY PRO SEQRES 12 B 416 ILE PHE VAL LEU VAL GLY VAL GLU HIS GLU GLN GLY THR SEQRES 13 B 416 ASP PRO TRP ASP THR ASN GLU CYS ARG PRO THR GLU PHE SEQRES 14 B 416 ALA VAL ARG SER GLY LEU LEU THR VAL MET VAL TRP VAL SEQRES 15 B 416 SER SER ILE PHE PHE PHE LEU PRO VAL PHE CYS LEU THR SEQRES 16 B 416 VAL LEU TYR SER LEU ILE GLY ARG LYS LEU TRP ARG ARG SEQRES 17 B 416 ARG GLY GLY THR THR MET ALA ASP LEU GLU ASP ASN TRP SEQRES 18 B 416 GLU THR LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA SEQRES 19 B 416 ASP ASN ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET SEQRES 20 B 416 ARG ALA ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO SEQRES 21 B 416 LYS LEU GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS SEQRES 22 B 416 ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE SEQRES 23 B 416 ASP ASP ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS SEQRES 24 B 416 GLU ALA GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG SEQRES 25 B 416 ASN ALA TYR ILE GLN LYS TYR LEU LEU ARG ASP GLN ASN SEQRES 26 B 416 HIS LYS GLN THR VAL LYS MET LEU ALA VAL VAL VAL PHE SEQRES 27 B 416 ALA PHE ILE LEU CYS TRP LEU PRO PHE HIS VAL GLY ARG SEQRES 28 B 416 TYR LEU PHE SER LYS SER PHE GLU PRO GLY SER LEU GLU SEQRES 29 B 416 ILE ALA GLN ILE SER GLN TYR CYS ASN LEU VAL SER PHE SEQRES 30 B 416 VAL LEU PHE TYR LEU SER ALA ALA ILE ASN PRO ILE LEU SEQRES 31 B 416 TYR ASN ILE MET SER LYS LYS TYR ARG VAL ALA VAL PHE SEQRES 32 B 416 ARG LEU LEU GLY PHE GLU PRO GLU ASN LEU TYR PHE GLN HET OLC A1201 18 HET OLC A1202 25 HET 1KQ A1203 37 HET OLC B1201 19 HET OLC B1202 16 HET OLC B1203 25 HET OLC B1204 25 HET 1KQ B1205 37 HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM 1KQ 2-(2-METHYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)-1-[2-[(1R)- HETNAM 2 1KQ 5-(6-METHYLPYRIMIDIN-4-YL)-2,3-DIHYDRO-1H-INDEN-1-YL]- HETNAM 3 1KQ 2,7-DIAZASPIRO[3.5]NONAN-7-YL]ETHANONE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 3 OLC 6(C21 H40 O4) FORMUL 5 1KQ 2(C29 H32 N6 O S) HELIX 1 AA1 PRO A 39 PHE A 71 1 33 HELIX 2 AA2 ARG A 72 ARG A 75 5 4 HELIX 3 AA3 THR A 76 TRP A 104 1 29 HELIX 4 AA4 PHE A 111 PHE A 147 1 37 HELIX 5 AA5 LYS A 157 LEU A 181 1 25 HELIX 6 AA6 THR A 201 GLY A 208 1 8 HELIX 7 AA7 GLY A 208 VAL A 230 1 23 HELIX 8 AA8 VAL A 230 TRP A 240 1 11 HELIX 9 AA9 THR A 1004 GLU A 1023 1 20 HELIX 10 AB1 ASN A 1027 LYS A 1047 1 21 HELIX 11 AB2 PRO A 1050 GLU A 1054 5 5 HELIX 12 AB3 SER A 1060 GLU A 1086 1 27 HELIX 13 AB4 LYS A 1088 GLN A 1108 1 21 HELIX 14 AB5 LYS A 1109 LEU A 1111 5 3 HELIX 15 AB6 ASN A 257 SER A 289 1 33 HELIX 16 AB7 SER A 294 SER A 327 1 34 HELIX 17 AB8 SER A 327 GLY A 339 1 13 HELIX 18 AB9 PRO B 39 PHE B 71 1 33 HELIX 19 AC1 THR B 76 GLN B 105 1 30 HELIX 20 AC2 PHE B 111 PHE B 147 1 37 HELIX 21 AC3 GLY B 158 GLY B 176 1 19 HELIX 22 AC4 PRO B 177 LEU B 181 1 5 HELIX 23 AC5 THR B 201 ARG B 206 1 6 HELIX 24 AC6 GLY B 208 VAL B 230 1 23 HELIX 25 AC7 VAL B 230 TRP B 240 1 11 HELIX 26 AC8 THR B 1004 ALA B 1025 1 22 HELIX 27 AC9 VAL B 1031 LYS B 1047 1 17 HELIX 28 AD1 PRO B 1050 GLU B 1054 5 5 HELIX 29 AD2 MET B 1063 GLU B 1086 1 24 HELIX 30 AD3 ALA B 1092 GLN B 1108 1 17 HELIX 31 AD4 ASN B 257 SER B 289 1 33 HELIX 32 AD5 LEU B 295 SER B 327 1 33 HELIX 33 AD6 SER B 327 ARG B 336 1 10 SHEET 1 AA1 2 VAL A 182 GLY A 183 0 SHEET 2 AA1 2 ARG A 199 PRO A 200 -1 O ARG A 199 N GLY A 183 SHEET 1 AA2 2 VAL B 182 GLY B 183 0 SHEET 2 AA2 2 ARG B 199 PRO B 200 -1 O ARG B 199 N GLY B 183 SSBOND 1 CYS A 116 CYS A 198 1555 1555 1.97 SSBOND 2 CYS B 116 CYS B 198 1555 1555 2.04 CRYST1 84.710 58.680 119.240 90.00 90.60 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011805 0.000000 0.000123 0.00000 SCALE2 0.000000 0.017042 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008387 0.00000